Singapore: Retina Institute Japan (RIJ), RIKEN, Japan, and Dainippon Sumitomo Pharma (DSP) have signed an agreement acco...
Singapore:Â Lantheus Medical Imaging, a global leader in developing, manufacturing and distributing innovative diagnos...
Singapore: A former employee of the Japanese drug maker Novartis, was arrested with allegations of data manipulation. So...
Eisai's UK subsidiary, Eisai Europe, has received a positive opinion from the European Medicines Agency's Committee for ...
Singapore: Takeda Pharmaceutical and H. Lundbeck A/S have submitted a new drug application (NDA) to the US Food and Drug...
Singapore:Â Boston Scientific's Japanese subsidiary has join hands with Fukuda Denshi to market and sell the former's ...
Singapore: Daiichi Sankyo's affiliate, the Japan Research Foundation for Clinical Pharmacology, has awarded its 5th Japa...
Singapore: FibroGen and Japanese company Astellas Pharma have initiated the first clinical study in the phase III clinic...
Singapore: Even as the industry is gearing up for BIOtech Japan 2014 that starts on May 14 at Tokyo Big Sight this year,...
Singapore: US-based Spiracur and Century Medical (CMI), Japan, have announced multiple system sales of the SNaP Wound Ca...
Singapore: Eisai signed an agreement with US-based Epizyme and Roche Molecular Systems to collaborate on the development...
Singapore: Dr Reddy's Laboratories Limited is planning to make a fresh foray into the Japanese market. "We are explorin...
Singapore: A team of scientists from Japan have created a functioning human liver from stem cells, raising hopes of manu...
Singapore: Nobelpharma and Eisai launched Gliadel 7.7 mg Implant (carmustine), an antineoplastic agent, in Japan on Janu...
Singapore: Takeda Pharmaceutical has submitted a new drug application (NDA) to the Ministry of Health, Labor and Welfare...
Singapore: University of Queensland (UQ) is soon going to globally launch a delicious berry-like ancient Chinese red bay...
Singapore: Sysmex Corporation and Siemens Healthcare Diagnostics have announced the signing of a five-year global supply...
Singapore:Â Sucampo (an affiliate of Sucampo Pharmaceuticals), R-Tech Ueno, Takeda Pharmaceutical, and certain affilia...
Japan's Chugai Pharmaceutical, which pursues cutting-edge biopharmaceutical, antibody, and molecular targeted research t...
Singapore:Â Eisai has received orphan drug designation from Japan's Ministry of Labour, Health and Welfare for its mul...
Singapore: Japan's health ministry has lodged a criminal complaint against the local wing of the leading Swiss drug make...
Singapore: Japan-headquartered Daiichi Sankyo has completed patient enrollment in the global Hokusai-VTE phase III study...
Singapore: Daiichi Sankyo is expanding its use of US-based Medidata Solutions' cloud-based platform to support clinical ...
Singapore:Â Daiichi Sankyo and Amplimmune have entered into a strategic collaboration to develop a new therapeutic pro...
Singapore:Â The independent Data Monitoring Committee (DMC) of the phase III MARQUEE (Met inhibitor ARQ 197 plus Erlot...
